GWN Securities’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.19M Sell
21,863
-4,669
-18% -$970K 0.87% 16
2026
Q1
$5.61M Sell
26,532
-2,787
-10% -$600K 1.07% 13
2025
Q4
$6.03M Sell
29,319
-551
-2% -$104K 1.22% 11
2025
Q3
$4.73M Sell
29,870
-2,556
-8% -$395K 1.09% 15
2025
Q2
$5.48M Sell
32,426
-5,725
-15% -$850K 1.02% 24
2025
Q1
$5.26M Buy
38,151
+26,791
+236% +$3.42M 0.3% 75
2024
Q4
$1.46M Buy
+11,360
New +$1.33M 0.39% 59

Other funds holding CAH

GWN Securities's CAH Position: Q2 2026 in Review

GWN Securities reduced its Cardinal Health (CAH) stake by 18% in Q2 2026, selling an estimated $970K and leaving 21,863 shares worth $5.19M. The position accounts for 0.87% of the portfolio, ranked #16.

GWN Securities first reported a position in CAH in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.03M in Q4 2025. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • GWN Securities held 21,863 shares of Cardinal Health worth $5.19M as of Q2 2026.
  • GWN Securities sold 4,669 Cardinal Health shares in Q2 2026, an estimated $970K.
  • Cardinal Health made up 0.87% of GWN Securities's portfolio in Q2 2026, its #16 holding.
  • GWN Securities first reported a position in Cardinal Health in Q4 2024 and has held it in 7 quarters since.
  • GWN Securities's Cardinal Health position peaked at $6.03M in Q4 2025.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on GWN Securities's 13F filing for Q2 2026, filed 5 Aug 2026.